U.S. Markets closed

Analysts’ Recommendations for GlaxoSmithKline Stock

Mike Benson
Analysts’ Recommendations for GlaxoSmithKline Stock

This year, analysts expect GlaxoSmithKline’s (GSK) revenue to grow 0.4% YoY (year-over-year) to ~30.3 billion British pounds from ~30.2 billion pounds, and its income margin to narrow YoY to 17.9% from 18.1%. They expect it to report EPS of 110.75 pence.